Larry J. Copeland, MD, discusses the importance of germline testing in ovarian cancer.
Larry J. Copeland, MD
Advertisement
Articles by Larry J. Copeland, MD
Larry J. Copeland, MD, discusses the prevalence of ovarian cancer in the United States.
Larry J. Copeland, MD, professor, Obstetrics & Gynecology, College of Medicine, The Ohio State University Comprehensive Cancer Center–James, discusses the use of PARP inhibitors in ovarian cancer.
Larry J. Copeland, MD, discusses the role of chemotherapy in ovarian cancer.
Larry J. Copeland, MD, discusses the etiology of ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Copeland on the Etiology of Ovarian CancerNovember 21st 2019
Dr. Copeland on the Role of Chemotherapy in Ovarian CancerJanuary 17th 2020
Dr. Copeland on the Use of PARP Inhibitors in Ovarian CancerFebruary 11th 2020
Dr. Copeland on the Prevalence of Ovarian Cancer in the United StatesFebruary 24th 2020
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
5